Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Four ACTs for Uncomplicated Malaria in Mozambican Children
NCT05343312Phase 4Completed
- Sponsor
- Manhiça Health Research Centre
- Start
- Mar 2022
- Primary completion
- Sep 2023
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, artesunate + amodiaquine, dihydroartemisinin + piperaquine, artesunate + pyronaridine in Plasmodium falciparum malaria, sponsored by Manhiça Health Research Centre. Started Mar 2022; status: completed.
02
Drugs
artemether + lumefantrineartesunate + amodiaquinedihydroartemisinin + piperaquineartesunate + pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT05343312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05343312.